Neurophysiology of Cannabinoids
Page Bibliography
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado
J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Epilepsia.
2014;55(6):791-802.
PubMed abstract / Full Text
Fine PG, Rosenfeld MJ.
The endocannabinoid system, cannabinoids, and pain.
Rambam Maimonides Med J.
2013;4(4):e0022.
PubMed abstract / Full Text
Koppel BS, Brust JC, Fife T, Bronstein J, Youssof S, Gronseth G, Gloss D.
Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development
Subcommittee of the American Academy of Neurology.
Neurology.
2014;82(17):1556-63.
PubMed abstract / Full Text
A systematic review of medical marijuana (1948-November 2013) to address treatment of symptoms of multiple sclerosis (MS),
epilepsy, and movement disorders.
Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.
Cannabinoids and Epilepsy.
Neurotherapeutics.
2015;12(4):747-68.
PubMed abstract / Full Text
This provides a review of current understanding of the endocannabinoid system, the pro- and anticonvulsive effects of cannabinoids
[e.g., Δ9-tetrahydrocannabinol and cannabidiol (CBD)], and evidence from pre-clinical and clinical trials of cannabinoids
in epilepsy.